The Quiet Influence of the Investment Committee

Most boards think of governance as the decisions made at the table. Which projects to fund. Which rules to amend. Which chair to appoint. The investment committee rarely makes that list. It is treated as a technical function, one room downstream from where the real decisions happen, a function that gets complimented when performance is strong and criticised when it falters. At most, the board will discuss fees and feel reassured when told the bank has offered special conditions.

There is more to it than that, considerably more.

In a classical grant making foundation, the invested capital is the larger sum by far, often twenty, forty, a hundred million francs or more. What goes out to projects is measured in thousands, perhaps five, fifteen, a hundred and twenty, occasionally a million in rarer cases. The attention a board gives to each side of that equation is rarely proportionate to its size. Often it is not even close.

I have seen versions of this dynamic in different institutions and from different seats around the table.

The banker managing that capital will tell you, correctly, that fiduciary responsibility and the investment guidelines define the boundary of the mandate, and that within that boundary the task is to optimise return for the foundation's risk tolerance and liquidity needs. Within that framing, some tensions resolve themselves easily. A tobacco holding alongside a grant to the lung association is the kind of conflict most institutional managers would call a simple exclusion, a screen applied at intake, hardly worth a board's attention.

The harder question sits one level deeper. Should a foundation hold private equity in foreign companies while its mission is to support Swiss entrepreneurs? Here the banker has a genuine argument, grounded in sound investment principles. Diversification is not a slogan. It is a real defence against concentration risk, and concentrating capital in Switzerland purely to mirror the mission could expose the foundation to exactly the kind of risk the investment guidelines exist to prevent. This is not a question with an obvious answer, which is precisely why it deserves a board's attention rather than its silence.

What this comes down to is whether a foundation understands itself as a single institution, where the investment side and the funding side are expressions of the same purpose rather than two unrelated functions sharing a balance sheet. Once a board accepts that framing, the conversation changes. It is no longer about whether the bank delivered acceptable returns. It is about whether the capital and the mission are pulling in the same direction, or where they diverge for reasons strong enough to defend out loud, and what to do when they cannot be defended at all.

That conversation is uncomfortable, and that is why it is worth having.

Perhaps there is something larger at stake. Foundations may be unusually interesting places to test whether purpose and capital can genuinely coexist.